FDA panel backs Kythera's double-chin treatment

FDA's Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted 17-0 to

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE